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ABSTRACT: Described herein is the development of a method to directly borylate the C5-position 
of monocyclic 1,2-azaborines without the use of a metal catalyst, kinetic resolution or directing 
group. This method tolerates different substitution on the boron as well as at the C3-position of 
the azaborine. A new BN-isostere of the drug molecule, felbinac, was synthesized to demonstrate 
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Selective Direct Borylation and Late-Stage Functionalization of 1,2-Azaborines 
 
1.1 Introduction to BN/CC Isosterism and Azaborines 
The concept of isosteres, or isosteric compounds, was first proposed by Irving Langmuir 
in 1919.1 Langmuir developed this concept when comparing the physical properties of carbon 
dioxide and nitrous oxide (Table 1.1). The similarities in their physical properties led Langmuir to 
further investigate this phenomenon. He subsequently found many other molecules that had 
properties closely related to one another and was able to solidify his definition. He described 
isosteres as having the same number and arrangement of electrons.1 This definition is not limited 
to describing chemical compounds, but also radicals or atoms which hold a pair of electrons in 
common. Langmuir’s introduction to isosterism opened many new doors and changed the way the 
chemical field evolved.  
Table 1.1: Comparison of Carbon Dioxide and Nitrous Oxide’s Physical Properties 
Property N2O CO2 
Critical pressure (atm.) 75 77 
Critical temp (°C) 35.4 31.9 
Viscosity at 20°C 148 x 10-6 148 x 10-6 
Heat conductivity at 100°C 0.0506 0.0506 
Density of liquid at –20°C 0.996 1.031 
Density of liquid at +10°C 0.856 0.858 
Refractive index of liquid, D line, 16°C 1.193 1.19 
Dielectric constant of liquid at 0°C 1.598 1.582 
Magnetic susceptibility of gas at 40 atm., 16°C 0.12 x 10-6 0.12 x 10-6 
Solubility in water at 0°C 1.305 1.78 
Solubility in alcohol at 15°C 3.25 3.13 
 







Throughout the years, the concept of an isostere has been expanded upon and modified. 
Through the pioneering work of Grimm,2 Penny and Southerland,3 the term has been adapted to 
include two additional properties, isoelectronic and isostructural. Though the definition is 
ambiguous, isoelectronic compounds are most widely defined as two or more species having the 
same total number of both atoms and electrons.4 Isostructural compounds are defined as two or 
more species being similar in atomic connectivity and structure. These two terms are closely 
associated and both are required for chemical compounds to be considered isosteres.  
Of the various isosteres known, one that has gained much interest over the years has been 
the isosterism between a carbon-carbon unit and a boron-nitrogen unit, typically referred to as 
BN/CC isosterism.5 BN/CC isosterism is particularly of interest because it allows for molecules to 
be built which are isoelectronic to their carbon analogues but display different electronic properties 
induced by the boron and nitrogen. The simplest comparison can be made using the hydrocarbon 
ethane (1.1) and its isostere, the ammonia-borane adduct (1.2). The first noticeable difference 
between these two compounds stems from their physical state of matter. At room temperature, 
ethane is a volatile gas while ammonia-borane is a solid due to its strong intramolecular 
interactions.6 In addition to the difference in physical properties, these compounds also differ in 
their electronic properties. 1.1 is a nonpolar molecule with a bond dissociation energy (BDE) of 
 
2 (a) Grimm, H. G. Z. Elektrochem. 1925, 31, 474–480.; (b) Grimm, H. G. Naturwissenschaften 1929, 17, 557–564. 
(c) Grimm, H. G.; Gunther, M.; Tittus, H. Z. Physik. Chem. 1931, 14, 169. 
3 Penney, W. G.; Sutherland, G. B. B. M. Force Constants of Triatomic Systems. 1936, 654–678. 
4 Rayner-Canham, G. Found. Chem. 2009, 11 (2), 123–129. 
5 For a brief overview, see: (a) Liu, Z.; Marder, T. B.; Angew. Chem. Int. Ed. 2008, 47, 242–244. (b) Angew. Chem. 
2008, 120, 248–250. (c) Bosdet, M. J. D.; Piers W. E. Can J. Chem. 2009, 87, 8–29. (d) Campbell, P. G.; Marwitz, 
A. J. V.; Liu, S.-Y. Angew. Chem. Int. Ed. 2012, 51, 6074–6092. (e) Giustra, Z. X.; Liu, S.-Y.; J. Am. Chem. Soc. 
2018, 140, 1184–1194. 






90.17 kcal mol-1 and contains only slightly acidic hydrogens due to the similarities in the 
electronegativity values of carbon and hydrogen. Conversely, 1.2 is a polar molecule that has a 
bond dissociation energy of 27.2 kcal mol-1 and a dipole moment of 4.9 debye.8,9 In addition, the 
hydrogens in the adduct are different in reactivity. Due to the differences in electronegativities, the 
hydrogens connected to the nitrogen are acidic while the hydrogens on the boron are hydridic 
(Figure 1.1).10 The differences in chemical nature of these hydrogens allow for the adduct to be 
much more reactive than its isosteric counterpart, ethane, thus accentuating the importance of 
BN/CC isosterism.  
Figure 1.1: Comparison of Properties between Isosteric Compounds Ethane and Ammonia-
Borane Adduct6,7,8,9 
 
The clearest example of BN/CC isosterism arises from the isosterism between ethene (1.3) 
and aminoborane (1.4). Similar to its saturated counterpart 1.1, 1.3 is volatile gas under standard 
pressure and temperature with no effective dipole moment and unreactive C-H bonds. It has a bond 
dissociation energy of 174.1 kcal mol-1, with the σ bond contributing 109.1 kcal mol-1 and the 𝜋 
bond contributing the remaining 65 kcal mol-1.7,11 Conversely, ethene’s BN analogue, 1.4, is 
 
7 Blanksby, S. J.; Ellison, G. B. Acc. Chem. Res. 2003, 36, 255–263. 
8 Grant, D. J.; Dixon, D. A. J. Phys. Chem. 2006, 110, 12955–12962.  
9 You, A.; Be, M. A. Y.; In, I. J. Chem. Phys. 1958, 29, 3–5. 
10 Qiu, B.; Wang, W.; Yang, X. Front. Chem. 2019, 7, 627–637. 






unstable at room temperature due to its reactive nature and propensity to polymerize. Despite this, 
Matsumura and coworkers12 were able to characterize the compound by microwave spectroscopy 
and found the molecule to have C2v symmetry with a planar structure similar to that of ethene, 
along with a dipole moment equal to 1.84 debye. Unlike 1.3, 1.4 has a much lower 𝜋 bond 
contribution of only 29.9 kcal mol-1 leading to an overall bond dissociation energy of 139.7 kcal 
mol-1 (Figure 1.2) .8  
Figure 1.2: Comparison of Properties between Isosteric Compounds Ethene and 
Aminoborane7,8,9,11 
1.1.1 Initial Discovery of Monocyclic Azaborines 
Expanding the sp2-type BN/CC isosterism to more complex molecules allows for the 
modification of the electronic properties of many different arenes and aromatic compounds. The 
first successful example of BN/CC isosterism in an aromatic compound was completed by Alfred 
Stock in 1926.13 Stock reported borazine (1.6), the first isostere of benzene (1.5) in which all of 
the CC double bonds were replaced with a BN unit. Stock’s initial report and characterization of 
1.6 sparked what would become decades long of interest and research into BN isosteres of aromatic 
compounds (Figure 1.3). 
 
12 Sugie, M.; Takeo, H.; Matsumura, C. Chem. Phys. Lett. 1979, 64, 573–575. 






Figure 1.3: BN/CC Isosterism between Benzene and Borazine 
 
  Since Stock’s development of benzene’s inorganic counterpart, Michael J. S. Dewar 
greatly expanded the field of BN/CC isosterism and introduced different examples of arene 
isosteres containing only one BN unit.14,15 Of particular interest are 1,2-azaborine derivatives, 
which are benzene isosteres where a BN unit replaces one CC double bond. These 1,2-azaborines 
served as a hybrid structure between the fully organic benzene and its inorganic counterpart, 
borazine. The first example of a monocyclic substituted 1,2-azaborine was synthesized by Dewar 
in 1962 through the desulfurization of compound 1.9 to afford 1.10 (Scheme 1.1, eq 1).16 Within 
the next year, White and coworkers synthesized their own 1,2-azaborine (1.14) which had no 






14 a) Dewar, M. J. S.; Kubba, V. P.; Pettit, R. J. Chem. Soc. 1958, 3073–3076. b) Dewar, M. J. S.; Dietz, R. J. Chem. 
Soc. 1959, 2728–2730. c) Dewar, M. J. S.; Gleicher, G. J.; Robinson, B. P. J. Am. Chem. Soc. 1964, 86, 5698–5699.  
15 Fritsch, A. J. Chem. Heterocycl. Compd. 1977, 30, 381–440. 
16 Dewar, M. J. S.; Marr, P. A. J. Am. Chem. Soc. 1962, 84, 3782. 






Scheme 1.1: Dewar and White’s Syntheses of 1,2-Azaborine Derivatives16,17 
 
1.1.2 New Developments of Azaborines 
After the initial syntheses of 1,2-azaborines by Dewar and White, the progress in this field 
slowed until a breakthrough by Ashe in 2000 revitalized the field. Ashe reported two 
straightforward syntheses of N-Et, B-Ph 1,2-azaborine (1.20) that featured a robust ring closing 
metathesis18 and a ring expansion method.19 In the first synthesis, allylboron dichloride (1.16) is 
generated in situ through the reaction of allyltributyltin (1.15) with boron trichloride. Subsequent 
reaction with ethyl allylamine in the presence of triethylamine resulted in the formation of adduct 
1.17 in 68% yield. This species then cleanly reacted with phenyllithium to give product 1.18 in 
81% yield and a subsequent ring closing metathesis with Grubbs first generation catalyst20 gave 
the six membered heterocycle 1.19 in 86% yield. The final aromatized product 1.20 was obtained 
in modest yield through a DDQ oxidation (Scheme 1.2, eq 1). The second synthesis proceeded 
through a ring closing metathesis of diallyl-adduct 1.21 to afford the five membered heterocycle 
 
18 Ashe, A. J., III; Fang, X. D. Org. Lett. 2000, 2, 2089–2091. 
19 Ashe, A. J.; Fang, X.; Fang, X.; Kampf, J. Organometallics, 2001, 20, 5413–5418. 






1.22 in 85% yield. Deprotonation with LDA resulted in the lithium azaborolide 1.23 in 77% yield 
and a final ring expansion gave the desired product 1.20 in 64% yield (Scheme 1.2, eq 2).  
Scheme 1.2: Ashe’s Syntheses of N-Et, B-Ph 1,2-Azaborine 
 
After Ashe’s breakthrough, the chemical field of azaborines exploded with newfound 
interest. Of particular note, Liu et al. reported the synthesis of N-TBS, B-Cl 1,2-azaborine (1.27) 






parent 1,2-dihydro-1,2-azaborine (1.31) in 2009.21 Liu’s new synthetic method still had a key ring 
closing metathesis step but afforded the desired azaborine in one less step (Scheme 1.3, eq 1). 
Besides this, the N-TBS, B-Cl 1,2-azaborine introduced an easily removable protecting group on 
the nitrogen and a labile B-Cl bond which is easily modified. These two features were key in finally 
achieving the synthesis of the parent azaborine. From 1.27, the B-H bond was installed through a 
nucleophilic substitution with LiBHEt3. It was found that complexation to “Cr(CO)3”  was 
necessary in order for desilylation to occur. The resulting adduct 1.29 was obtained in 71% yield. 
The N-protecting group was then removed and a final decomplexation with PPh3 afforded the 

















Scheme 1.3: Liu’s Syntheses of N-TBS, B-Cl 1,2-azaborine and the Parent 1,2-dihydro-1,2-
azaborine21 
 
Consistent with BN/CC isosterism, 1,2-dihydro-1,2-azaborine (1.31) is similar in structure 
to benzene but displays distinct electronic properties. Like its carbonaceous analogue, 1.31 
displays aromaticity with a calculated resonance stabilization energy of 19.6 kcal mol-1.22 Unlike 
its analogue, it has both a hydridic and acidic proton which is capable of hydrogen bonding,23 as 
 
22 Campbell, P. G.; Abbey, E. R.; Neiner, D.; Grant, D. J.; Dixon, D. A.; Liu, S.-Y. J. Am. Chem. Soc. 2010, 132, 
18048–18050.  






well as a dipole moment of 2.154 debye.24 Besides the 1,2-azaborine isostere, there also exists the 
1,3-dihydro-1,3-azaborine (1.32) and 1,4-dihydro-1,4-azaborine (1.33) isosteres, that also display 
distinct electronic properties but are not as prevalent as 1,2-azaborines, which are the focus of this 
work (Figure 1.4). 
Figure 1.4: BN/CC Isosterism between Benzene and Azaborine Isomers 
 
1.1.3  Importance of Azaborines in Medicinal Chemistry 
The different electronic properties displayed in azaborines can be utilized to expand upon 
the properties of current drug molecules. The BN analogues of arenes are of interest due to the 
abundance of arenes and aromatic compounds in biomedical research. The first example of 
azaborines interacting with a biological system was shown by Liu, Matthews, and coworkers in 
2009 where they demonstrated that azaborines had the capability to bind inside a nonpolar cavity 
 
24 Chrostoswka, A.; Xu, S.; Lamm, A. N.; Mazière, A.; Weber, C. D.; Dargelos, A.; Baylère, P.; Graciaa, A.; Liu, S.-






of a mutated T4 lysozyme via a Leu99Ala mutation.25 The BN analogues of benzene and 
ethylbenzene were synthesized and their binding abilities compared to the carbon analogues. It 
was found that the azaborines have the capability to bind in the aryl recognition pockets and that 
both the parent 1,2-azaborine (1.31) and N-ethyl-1,2-azaborine (1.34) bind with almost 100% 
occupancy (40% more occupancy than ethylbenzene). Additionally, similar work by Liu showed 
that 1.31 and B-ethyl-1,2-azaborine (1.35) can bind in a double mutated polar pocket of T4 
lysozyme developed by Matthews in which methionine 102 is mutated to a glutamine residue 
(Figure 1.5).23  It was found through high-resolution protein X-ray crystallography that the NH 
group of 1.31 and 1.35 engages in hydrogen bonding with the oxygen of the mutated glutamine 
residue in the pocket. The observed distances between the NH group of the azaborines and the 
Gln102 carbonyl oxygen is 3.1 Å and 3.2 Å for 1.31 and 1.35, respectively. The binding energies 
of hydrogen bonding between the Gln102 carbonyl oxygen and NH of the parent azaborine, as 
well as the NH of 1.35 were estimated to be −0.94 and −0.64 kcal/mol, respectively. Finally, 
further studies into the strength of the hydrogen bond showed that bulkier groups on the boron of 
the azaborine lead to weaker hydrogen bonds.26 




25 Liu, L.; Marwitz, A. J. V.; Matthews, B. W.; Liu, S.-Y. Angew. Chem. Int. Ed. 2009, 48, 6817 –6819. 






After these initial discoveries, Liu, Heider, Szaleniec, and coworkers expanded upon this 
work by showing that the same azaborine isosteres of ethylbenzene could also act as enzyme 
inhibitors.27 Ethylbenzene dehydrogenase (EbDH) is a molybdenum enzyme, which belongs to the 
DMSO reductase family that catalyzes the stereoselective hydroxylation of ethylbenzene to (S)-1-
phenylethanol in anaerobic conditions.28 While ethylbenzene acts as a substrate for EbDH, Liu et 
al. was able to show that both B- and N-ethyl BN isosteres of ethylbenzene are strong inhibitors 
of ethylbenzene dehydrogenase. It was found that 1.35 had an IC50 value of 100 μM, whereas 1.34 
was more potent with an IC50 value of only 2.8 μM. Upon further investigation, it was seen that 
1.35 had a slightly different orientation in the binding site, accounting for the decreased inhibitory 
effect. These differences between ethylbenzene and its BN isosteres prove that not only can 
BN/CC isosterism be applied in a biological context but it can also lead to unique behavior.  
After showing azaborines could be applied in a biological setting, Liu and coworkers were 
also able to synthesize the first examples of biologically active monocyclic 1,2-azaborines.29 They 
synthesized the BN analogues of 3 known biologically active biphenyl carboxamides (biaryls are 
considered to be privileged structures30) and evaluated their bioactivities in comparison to their 
carbonaceous isosteres. Compounds BN-1, BN-2, and BN-3 have been synthesized as the isosteres 
of dopamine receptor D3, PPAR γ and δ, and CDK2 inhibitors, respectively, and were shown to 
be air and water stable. D3 is a dopamine receptor protein in humans and is a target for drugs that 
 
27 Liu, L.; Marwitz, A. J. V.; Matthews, B. W.; Liu, S.-Y. Angew. Chem. Int. Ed. 2013, 52, 2599 –2601. 
28 Johnson, H. A.; Pelletier, D. A.; Spormann, A. M. J. Bacteriol. 2001, 183, 4536–4542. 
29 Zhao, P.; Nettleton, D. O.; Karki, R. G.; Zécri, F. J.; Liu, S.-Y. ChemMedChem 2017, 12, 358–361. 






treat neurological disorders including: Parkinson’s disease, schizophrenia and drug abuse.31,32 It’s 
analogue, BN-1, was shown to have an increased solubility, as well as an IC50 value of 3 nM. 
PPAR γ and δ are nuclear receptor proteins that regulate the expression of genes.33 These proteins 
have been involved in the development of numerous diseases including diabetes, obesity, 
atherosclerosis and cancer and their antagonists have been used to treat hyperlipidemia and 
hyperglycemia.34,35 Its corresponding BN-2 compound again had an increased solubility and IC50 
values of 2 nM and 1 nM for PPAR γ and δ, respectively. Finally, CDK2 is a serine/threonine 
protein kinase that was reported as a potent nanomolar antiproliferate agent.36 CDK2 antagonists 
have been found to be useful for chemotherapy and chemoprevention against certain cancers.37 
Again, its BN isostere, BN-3, showed an improved solubility, as well as an improved IC50 value 






31 Joyce, J. N.; Millan, M. J. Current Opinion in Pharmacology. 2007, 7, 100–105. 
32 Maramai et al. Front. Neurosci. 2016, 10, 1–16. 
33 Michalik, L.; Wahli, W. Pharmacol. Rev. 2006, 58, 726–741. 
34 (a) Berger, J.; Moller, D. E.  Annu. Rev. Med. 2002, 53, 409–435. (b) Feige, J. N.; Gelman, L.; Michalik, L.; 
Desvergne, B.; Wahli, W. Prog. Lipid Res. 2006, 45, 120–159. 
35 (a) Lehrke, M.; Lazar, M. A.; Cell. 2006, 123, 993–999. (b) Kim, J. H.; Song, J.; Park, K. W.; Arch. Pharmacal. 
Research 2006, 38, 302–212. 
36 Pevarello, P.; Warpehoski, M. A. J. Med.Chem. 2004, 47, 3367–3380. 
37 Peng, C.; Zeng, W.; Su, J.; Kuang, Y.; He, Y.; Zhao, S.; Zhang, J.; Ma, W.; Bode, A. M.; Dong, Z.; Chen, X. 






Figure 1.6: Comparison of Biologically Active Molecules to Their BN-Analogues29 
 
The improved solubility of each BN antagonist can be attributed to the introduction of the polar 
B-N bond unit, rendering the molecule to be less hydrophobic. As a result of the improved 
solubility, BN-3 showed improved in vivo pharmokinetic behavior, including a doubled AUCpo, 
higher bioavailability, and a longer terminal half-life (Figure 1.7). The observed improved 
biological activity is likely a result of the NH group acting as a hydrogen bond donor. It can be 






backbone of Ile10 in the ATP binding pocket. These results with the BN analogues highlight the 
importance of incorporating azaborines into bioactive molecules and emphasize the need to be 
able to functionalize these azaborines at their different positions for the synthesis of compound 
libraries. 
Figure 1.7: Bioactivities of the CDK2 Inhibitor versus the BN-Analogue  
 
1.1.4 Present Gap in Azaborine Functionalization 
To expand the chemical space of azaborines, there must be  methods to functionalize each 
position of the azaborine. This would allow for new biomimetics and BN drug molecules to be 
developed and used in a medical setting. Fortunately, due to the lack of symmetry present in 
azaborines, each position is chemically independent.38 The distinction in chemical character allows 
for specific positions to be selectively functionalized. There have been methods developed to 
 






selectively incorporate different functional groups on the boron and nitrogen atoms.39,40 Similarly, 
procedures have been developed to selectively functionalize both C3 and C6 of the carbon 
backbone (vide infra). However, there are very few methods developed to directly functionalize 
the C5 carbon.41,42,43 To date, there has yet to be a method developed to directly and selectively 
borylate the C5 carbon.  
Figure 1.8: Position Labelling for the Monocyclic 1,2-Azaborines 
 
The ability to directly functionalize the position para to the boron would also expand the 
chemical space of biphenyl motifs. So far, these structures have only been accessed through the 
aryl substitution on the boron (vide supra). However, installation of different functional groups at 
the C5-position would allow for an unsubstituted phenyl ring to be present on the boron in the 
biphenyl and thereby further expand the structural diversity. This work describes a new 





39 Marwitz, A. J. V.; Abbey, E. R.; Jenkins, J. T.; Zakharov, L. N.; Liu, S.-Y. Org. Lett. 2007, 9, 4905−4908. 
40 Lamm, A. N,; Garner, E. B,; Dixon, D. A.; Liu, S.-Y. Angew. Chem. Int. Ed. 2011, 50, 8157−8160. 
41 Zhang, Y.; Sun, F.; Dan, W.; Fang, X. J. Org. Chem. 2017, 82, 12877−12887.  
42 Zhang, Y.; Dan, W.; Fang, X. Organometallics, 2017, 36, 1677−1680. 






1.2  Direct Borylation of Arenes 
1.2.1 Background 
C-H borylation has been developed and explored over the years as an important 
transformation in organic chemistry.44 The introduction of the versatile C-B bond generates new 
organoboron reagents45 that can be used as a linchpin to construct pharmaceuticals and natural 
products.46 Among the methods known to incorporate these bonds, transition metal-catalyzed 
reactions are well established.47 Similarly, alternative procedures have been developed that do not 
require the use of a metal to integrate the C-B bond.48 These reactions can be achieved simply 
through the use of boron halides as the borylation reagent. Despite the difference in conditions, 
both of these methods have the capability to introduce a versatile functional group (i.e. Bpin), 
which can be transformed into various groups including: halogens,49 perfluoroalkyl,50 OH,51 OR,52 
 
44 For representative reviews, see: (a) Mkhalid, I. A. I.; Barnard, J. H.; Marder, T. B.; Murphy, J. M.; Hartwig, J. F. 
Chem. Rev. 2010, 110, 890–931. (b) Hartwig, J. F. Acc. Chem. Res. 2012, 45, 864−873. (c) Piers, W. E.; Bourke, S. 
C.; Conroy, K. D. Angew. Chem. Int. Ed. 2005, 44, 5016−5036. (d) De Vries, T. S.; Prokofjevs, A.; Vedejs, E. 
Chem. Rev. 2012, 112, 4246−4282. 
45 (a) Pelter, A.; Smith, K.; Brown, H. C. Borane Reagents; Academic: London, 1988. (b) Hall, D. Boronic Acids: 
Preparation and Applications in Organic Synthesis, Medicine and Materials, 2nd ed.; WileyVCH: Weinheim, 2011. 
(c) Suzuki, A. Angew. Chem. Int. Ed. 2011, 50, 6722−6737. (d) Oeschger et al., Science, 2020, 368, 736–741. 
46 (a) Matteson, D. S. Stereodirected Synthesis with Organoboranes; Springer: Berlin, 1995. (b) Suzuki, A. Angew. 
Chem. Int. Ed. 2011, 50, 6722−6737. 
47 (a) Mkhalid, I. A. I.; Barnard, J. H.; Marder, T. B.; Murphy, J. M.;  Hartwig, J. F. Chem. Rev. 2010, 110, 
890−931. (b) Hartwig, J. F. Chem. Soc. Rev. 2011, 40, 1992−2002. (c) Hartwig, J. F. J. Am. Chem. Soc. 2016, 138, 
2−24. 
48 Ingleson, M. J. Synlett 2012, 1411−1415. 
49 (a) Fier, P. S.; Luo, J.; Hartwig, J. F. J. Am. Chem. Soc. 2013, 135, 2552−2559. (b) Murphy, J. M.; Liao, X.; 
Hartwig, J. F. J. Am. Chem. Soc. 2007, 129, 15434−15435. (c) Partridge, B. M.; Hartwig, J. F. Org. Lett. 2013, 15, 
140−143. 
50 (a) Litvinas, N. D.; Fier, P. S.; Hartwig, J. F. Angew. Chem. Int. Ed. 2012, 51, 536−539. (b) Min, Q.-Q.; Yin, Z.; 
Feng, Z.; Guo, W.-H.; Zhang, X. J. Am. Chem. Soc. 2014, 136, 1230−1233. 
51 (a) Matteson, D. S.; Ray, R. J. Am. Chem. Soc. 1980, 102, 7591−7593. (b) Kabalka, G. W.; Shoup, T. M.; 
Goudagaon, N. M. Tetrahedron Lett. 1989, 30, 1483−1486. (c) Xu, J.; Wang, X.; Shao, C.; Su, D.; Cheng, G.; Hu, 
Y. Org. Lett. 2010, 12, 1964−1967. (d) Zou, Y.-Q.; Chen, J.-R.; Liu, X.-P.; Lu, L.-Q.; Davis, R. L.; Jorgensen, K. 
A.; Xiao, W.-J. Angew. Chem. Int. Ed. 2012, 51, 784-788. (e) Fier, P. S.; Hartwig, J. F. Angew. Chem. Int. Ed. 2013, 
52, 2092−2095. 






NH2,53 B(OH)2,54 and BF3K.55 This ability to introduce a wide range of new functional groups 
allows for a new way to diversify arenes through C-H borylation.  
1.2.2 Iridium Catalyzed C-H Borylation 
 Transition metal catalyzed C-H borylation of arenes was first fully developed in 1995 by 
Hartwig and coworkers, used (CO)5MnBcat, (CO)5ReBcat, and CpFe(CO)2Bcat as catalysts to 
borylate both benzene and toluene.56 Since this initial discovery, many transition metals have been 
utilized as the catalyst, 47a but of these iridium complexes have been shown to be particularly 
successful. Smith and Iverson were the first to report the C-H borylation of an unreactive arene 
using an Cp*Ir (PMe3)(H)(Bpin) (1.36) (Scheme 1.4).57  
Scheme 1.4: Smith and Iverson’s Borylation Reaction of Benzene using an Iridium Catalyst 
 
This reaction provided a novel way to directly borylate unreactive arenes however, it was 
limited by a turnover number of only 3. Despite the lack of efficiency in the reaction, Hartwig and 
coworkers58 expanded upon their previous work and developed efficient and milder conditions to 
 
53 (a) Tzschucke, C. C.; Murphy, J. M.; Hartwig, J. F. Org. Lett. 2007, 9, 761−764. (b) Mlynarski, S. N.; Karns, A. 
S.; Morken, J. P. J. Am. Chem. Soc. 2012, 134, 16449−16451. 
54 (a) Matteson, D. S.; Jesthi, P. K.; Sadhu, K. M. Organometallics, 1984, 3, 1284−1288. (b) Sun, J.; Perfetti, M. T.; 
Santos, W. L. J. Org. Chem. 2011, 76, 3571−3575 
55 Murphy, J. M.; Tzschucke, C. C.; Hartwig, J. F. Org. Lett. 2007, 9, 757−760. 
56 Waltz, K. M.; He, X.; Muhoro, C.; Hartwig, J. F. J. Am. Chem. Soc. 1995, 117, 11357. 
57 Iverson, C. N.; Smith, M. R. J. Am. Chem. Soc. 1999, 121, 7696−7697. 
58 (a) Waltz, K. M.; Muhoro, C. N.; Hartwig, J. F. Organometallics 1999, 18, 3383–3393. (b) Takagi, J.; Sato, K.; 






borylate different arenes and heteroarenes. In collaboration with Ishiyama and Miyaura, they 
catalyzed the borylation of arenes and heteroarenes at room temperature using 
1/2[Ir(OMe)(COD)]2 (1.38) complexes with air stable 2,2’-bipyridines and stoichiometric amount 
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Miyaura, N.; Anastasi, N. R.; Hartwig, J. F. J. Am. Chem. Soc. 2002, 124, 390−391. 






Table 1.2: C-H Borylation of Arenes and Heteroarenes using an Ir(I) Complex59 
 
 It was found that for these reactions with arenes, sterics seemed to govern the selectivity. 
Conversely, further investigation revealed that using the same conditions on heteroarenes lead to 
selectivity largely controlled by electronic effects.59,60,61 The reaction occurs at the C-H bond alpha 
 
60 Ishiyama, T.; Takagi, J.; Yonekawa, Y.; Hartwig, J. F.; Miyaura, N. Adv. Synth. Catal. 2003, 345, 1103–1106. 
61 Vanchura, I. I. B. A.; Preshlock, S. M.; Roosen, P. C.; Kallepalli, V. A.; Staples, R. J.; Maleczka, J. R. E.; 






to the heteroatom and even in the case of benzo-fused heterocycles, no reaction occurs at the 
benzene ring. However, it is possible to modify this selectivity using steric effects. If a nitrogen-
containing heteroarene contains a large substituent on the nitrogen atom, the reaction takes place 
beta to the nitrogen.50,62  
 The development of iridium catalyzed C-H borylation not only leads to a higher functional 
group tolerance with more mild conditions,58d but it could also be utilized as a key step in the 
synthesis of active pharmaceutical ingredients and natural products (Scheme 1.5). In 2008, Gaunt 
and coworkers reported the synthesis of the pyrrole alkaloid rhazinicine (1.39) through the iridium 
catalyzed C-H borylation of an N-Boc-pyrrole derivative.62 Similarly, Sarpong and coworkers were 
able to take advantage of the selectivity of pyridine borylation to synthesize the alkaloid (+)-
complanadine A (1.40).63 The installation of the beta boryl group allowed for a Suzuki-Miyaura 
cross coupling to form the biaryl bond in their final steps. Additionally, Hartwig and coworkers 
were able to synthesize the natural product (-)-taiwaniaquinol B (1.41) through an α-arylation of 
the aryl halide that was generated after C-H borylation and subsequent halogenation.64 More 
recently, Szostak and coworkers were able to prepare febuxostat (1.42) via the iridium catalyzed 





62 Beck, E. M.; Hatley, R.; Gaunt, M. J. Angew. Chem., Int. Ed. 2008, 47, 3004–3007. 
63 Fischer, D. F.; Sarpong, R. J. Am. Chem. Soc. 2010, 132, 5926–5927. 
64 Liao, X.; Stanley, L. M.; Hartwig, J. F. J. Am. Chem. Soc. 2011, 133, 2088–2091. 






Scheme 1.5: Natural Products Synthesized through Iridium-Catalyzed C-H Borylation  
 
 
1.2.3 Metal-Free C-H Borylation using Boron Trihalides 
 The first example of C-H borylation using boron halides came from Dewar’s initial report 
on azaborine synthesis in 1958. He synthesized a BN phenanthrene derivative through the reaction 
between 2-aminodiphenyl and boron trichloride, followed by a reduction.14a Similarly, in 1963, 
MacLean and coworkers prepared 2-(2-boronophenyl)-benzimidazole (1.44) and 2-(2-
boronobenzyl)-benzimidazole (1.46) using boron trichloride. Both 2-phenylbenzimidazole (1.43) 
and 2-benzylbenzimidazole (1.45) were subjected to a stream of boron trichloride at 300 °C and 
subsequently hydrolyzed to give their respective products, 1.44 and 1.46 (Scheme 1.6).66 Due to 
 






the success of these reactions, other works were published achieving similar chemistry67 however, 
the harsh conditions required, along with a limited substrate scope, led to a lull in activity 
surrounding borylation through boron trihalides.  
Scheme 1.6: Initial C-H Borylation using Boron Halides and Harsh Conditions66 
 
 In 2010, Murakami et al. developed a mild borylation of 2-arylpryridines at room 
temperature using boron tribromide as the borylating reagent and diethylisopropylamine as the 
base.68 The reaction gave pyridine–dibromoborane complexes in high yields, which could be 
transformed into pyridine–(dialkyl/diaryl)boranes through treatment with organometallic reagents 
or reduction with LAH. They were able to devise a plausible mechanism for the formation of these 
products (Scheme 1.7). The Lewis acidic boron of the BBr3 (1.48) can coordinate to the Lewis 
basic nitrogen of the pyridine (1.47) to form complex 1.49. A bromide is then abstracted from 1.49 
 
67 (a) Koster, R.; Iwasaki, K. Advan. Chem. Ser. 1964, 42, 148. (b) Koster, R.; Iwasaki, K. Chem. Abstr., 1964, 60, 
10705. 






by another BBr3 to afford the borenium ion69 (1.50). The electrophilic borenium ion then attacks 
the corresponding aromatic ring to yield the Wheland intermediate70 (1.51). Finally, base assisted 
loss of the proton rearomatizes the ring and furnishes the desired product (1.52).68 
Scheme 1.7: Plausible Mechanism for the Borylation of 2-arylpyridines using BBr368 
 
Recently, Shi et al. and Ingleson et al. both published metal-free, acyl-directed borylations 
using boron tribromide.71,72 Shi demonstrated how using an acyl directing group in conjunction 
with BBr3 allows for the borylation of various substituted indole moieties at both the C7- and C4-
positions as well as different heteroarenes. The reactions were carried out at room temperature and 
subsequently reacted with pinacol and pyridine to afford the Bpin functional group (Scheme 1.8, 
top). To show the application of their reaction, they conducted a cascade C-H boryation/C-C and 
C-Het bond formation through Suzuki-Miyuara cross coupling to form different natural products. 
Similarly, Ingleson borylated indole moieties at the C7-position using an acyl directing group, but 
 
69 (a) Ryschkewitsch, G. E.; Miller, V. R. J. Am. Chem. Soc. 1973, 95, 2836-2839. (b) Kolle, P.; Noth, H. Chem. 
Rev. 1985, 85, 399–418. (c) Piers, W. E.; Bourke, S. C.; Conroy, K. D. Angew. Chem., Int. Ed. 2005, 44, 5016–
5036. (d) Chiu, C.-W.; Gabbai, F. P. Organometallics 2008, 27, 1657–1659. 
70 Wheland, G. W. J. Am. Chem. Soc., 1942, 64, 900–908. 
71 Shi, Z.; et. al. Nature 2019, 575, 336–340. 







could also achieve ortho-borylation of aniline derivatives. Conversely, some of the reactions 
needed to be heated to 60 °C in order to achieve significant borylation. They were also able to 
remove the N-pivaloyl group of the indole via the addition of methanol in the second step and 
heating to 60 °C (Scheme 1.8, bottom). These two examples of metal-free C-H borylation of 
heteroarenes were the inspiration for the development of our new method (vide infra). 













1.3 Direct Borylation of Azaborines 
1.3.1 Background 
 It has been demonstrated that BN-arenes are capable of undergoing C-H borylation as 
well.38 The lack of symmetry present in the azaborines leads to unique reactivity of each position 
of the carbon backbone. The distinction in chemical character allows for site selective borylation 
to occur. The C3-position is the least acidic, but due to resonance of the azaborine, it has a partial 
negative charge and is the most electron rich carbon, allowing for it to undergo electrophilic 
aromatic substitution reactions (EAS).43 This is also consistent with its upfield shifted NMR 
signal.5d C4 has the most downfield proton, which is typical of protons that undergo C-H activation 
in borylation reactions. Similar to C3, C5 has a partial negative charge due to resonance and can 
readily undergo EAS reactions. Finally, C6 is the most acidic position of the carbon backbone with 
a pKa of 43 making it easier to undergo borylation reactions (Figure 1.9, calculated pKa 
(B3LYP/DZVP2) values in H2O, G3MP2 bond dissociation energies (BDE) for the corresponding 
C−H bonds).37 It has been shown that depending on the substitution patterns, borylation can occur 












Figure 1.9: NMR Shifts and pKa’s of each Hydrogen Around the Parent 1,2-Azaborine21, 38 
 
1.3.2 Iridium Catalyzed C-H Borylation of C6 
 When testing iridium catalyzed C-H borylation conditions on B-substituted 1,2-azaborines, 
it was found that borylation occurs at the site of the most acidic proton, the C6-position.38 This 
selectivity is also consistent with the observation that C-H borylation of nitrogen-containing 
heteroarenes occurs alpha to the nitrogen.60 The functionalization at C6 was of particular interest 
because it could allow for the access of new κ2-N,N-bidentate ligands through Suzuki cross 
coupling.  
 Various B-substituted 1,2-azaborines were reacted with the (1,5-cod)(methoxy)iridium (I) 
dimer in the presence of 4,4'-di-tert-butyl-2,2'-bipyridine (dtbpy) and bis(pinacolato)diboron 







tolerate various functional groups on the 1,2-azaborine boron including aryl, alkyl,74 and an 
alkoxide group (Table 1.3).38 Further substitution could also be tolerated at the C3 position as 
well.75  
Table 1.3: Substrate Scope for C-H Borylation of 1,2-Azaborine 
 
entry substrate product yield (%) 
1 1.31 (R = H) 2.31 71 
2 1.53 (R = Me) 2.53 67 
3 1.54 (R = n-Bu) 2.54 86 
4 1.55 (R = Ph) 2.55 75 
5 1.56 (R = Mes) 2.56 92 
6 1.57 (R = O-n-Bu) 2.57 66 
    
 Once the borylated products were in hand, they could be subjected to Suzuki cross coupling 
conditions to install various arenes and heteroarenes. Furthermore, these new azaborines 
containing nitrogen heteroarenes had the potential to act as novel κ2-N,N-bidentate ligands.  
1.3.3 Unselective Borylation with Iridium Catalyst 
 Besides selective C6 borylation, it was found that N,B-disubstituted 1,2-azaborines could 
also be borylated at the C5- and C4-positions using similar conditions. Reacting N-TBS, B-Mes-
1,2-azaborine (1.59) with the (1,5-cyclooctadiene)(methoxy)iridium (I) dimer in the presence of 
 
74 Baggett, A. W.; Liu, S.-Y. J. Am. Chem. Soc. 2017, 139, 15259–15264. 








4,4'-Di-tert-butyl-2,2'-bipyridine (dtbpy) and bis(pinacolato)diboron (B2pin2) yields a mixture of 
1 to 1.2-1.4 C4- and C5-borylated regioisomers (C5Bpin and C4Bpin) (Scheme 1.9).73 
Scheme 1.9: C4- and C5-Borylation of N-TBS, B-Mes-1,2-Azaborine73 
 
 However, in order to be able to utilize these new building blocks, they had to be isolated 
as single products. To achieve this, kinetic resolution was required. To isolate C4Bpin, the mixture 
is subjected to the iridium dimer catalyst in the presence of methanol to yield the desired product 
in 25% yield with starting material (1.59) as byproduct (Scheme 1.10). This method is successful 
because the C5-position has stronger nucleophilic character so it favors transition-metal mediated 
protodeborylation. 







 Additionally, to afford the C5 borylated product, the mixture reacted with NMO to yield 
isolated C5Bpin in 53% yield with C4OH as the byproduct (Scheme 1.11). This reaction could 
successfully act as a kinetic resolution because the rate of NMO oxidation with C4Bpin was 29 
times faster than the decomposition of C5Bpin in the presences of NMO. 
Scheme 1.11: Kinetic Resolution using NMO to Isolate C5Bpin 
 
 The importance of isolating both C4Bpin and C5Bpin was demonstrated by the fact that 
they could undergo Suzuki-Miyaura cross-coupling with various aryl halides and act as building 
blocks for more complex molecules.  
1.4 Metal-Free Selective Borylation of C5 
1.4.1 Introduction 
 While borylation can occur selectively at C6 and unselectively at both C4- and C5- 
positions with the use of an iridium catalyst, there has yet to be a method in which the C5-position 
of the azaborine can be selectively functionalized. Herein, we report the successful development 
of a method to selectively borylate the C5-position with no need for a kinetic resolution, transition 






1.4.2 Initial Discovery and Optimization 
Literature precedent for this new reaction came from the Shi and Ingelson papers that were 
recently published.71,72 When implementing similar conditions with our azaborine, it was observed 
that borylation occurred selectively at the C5-position without the need for a directing group. In 
order to fully exploit this reactivity, various conditions were tested to afford C5-substitution as the 
product. 
 We chose N-TBS, B-Mes-1,2-azaborine (1.59) as our model reactant to optimize the 
borylation conditions. It was found that reacting 1.59 with 3 equivalents of BBr3 and 3 equivalents 
of 2,6-ditertbutylpyridine (DTBP) in tetrachloroethane (TCE) at 140 °C for 2 hours, the reaction 
yielded 90% C5-borylated product (Table 1.4, entry 1). We tested different boron reagents and 
saw no product formation with either BCl3 or BF3·OEt2 (entries 2-3). Use of different solvents led 
to a diminished yield (entries 4-5) and similarly, changing the base also led to no product formation 
(entries 6-7) suggesting that a bulky, non-nucleophilic base was necessary. Upon lowering the 
temperature, a decrease in yield was observed consistent with the reaction proceeding slower than 
at an elevated temperature (entries 8-9). Finally, it can be seen that with less equivalents of base 
or BBr3, the yield is decreased. (entries 10-12). The most dramatic decrease in yield can be seen 
when the equivalents of BBr3 is changed from 2 equivalents to 1. This result is consistent with the 
BBr3 molecules first disproportionating to form the more reactive borenium cation before 
undergoing attack by the azaborine. This mechanism is consistent with previously reported 








Table 1.4: Optimization Scope for C5-Borylation Reaction 
 
entry deviation yield (%)a 
1 none 90 (83) 
2 BCl3 instead of BBr3 0 
3 BF3·OEt2 instead of BBr3 0 
4 toluene as the solvent  65 
5 bromobenzene as the solvent  76 
6 Et3N instead of DTBP 0 
7 2,6-lutidine instead of DTBP 0 
8 Reaction temperature 80 ˚C 59 
9 Reaction temperature 50 ˚C 40 
10 DTBP (2 equiv.) 65 
11 BBr3 (2 equiv.) 83 
12 BBr3 (1 equiv.) 27 
   
aNMR yield 
  
1.4.3 Substrate Scope 
With the optimized conditions in hand, different substrates were tested to identify the scope 
of the reaction. The model substrate 3a could be isolated in up to 83% yield as the Bpin derivative. 
Further substitution could be tolerated at the C3 position affording the tetra-orthogonal azaborine 
(Table 1.5, 3b). Various substituents on the boron could also be tolerated under these conditions 
(Table 1.5, 3c-f). However, when a chloro group was present on the boron, the intermediate could 
not be trapped with pinacol due to the reactivity of the B-Cl bond so only an NMR yield is reported. 
Additionally, when a phenyl ring is attached to the boron of the azaborine, a mixture of 






monoborylated C5 and monoborylated C3 isomers is isolated in an 80:20 ratio. When allowed to 
run for longer, the diborylated product, 3e, can be isolated cleanly.  
Table 1.5: Substrate Scope for C5-Borylation Reaction 
 
 It was found that when 3a was resubjected to the standard conditions, no borylation 
occurred at the C3 position. This suggests that in the presence of a boronate ester group, the BBr3 
is consumed by converting the Bpin group into the BBr2 intermediate, resulting in an insufficient 
amount of BBr3 to add to the C3 position. However, it is expected that a different substituent at 
C5 would be tolerated and lead to C3 borylation. It was also found that when an ethyl group is 
present at the C4-position, 2g, a mixture is obtained with 7% C5- and 21% C3- borylated BN  







Scheme 1.12: C4-Substituted Product 
 
1.4.4 Synthesis of BN-Felbinac 
 To demonstrate the applications of this reaction, we sought out to synthesize a biphenyl 
drug molecule. We chose to focus our attention on biphenyl systems because they are considered 
privileged motifs in medicinal chemistry.30 We decided to synthesize the BN-isostere of Felbinac, 
a nonsteroidal anti-inflammatory drug (NSAID), which is used to treat muscle inflammation and 
arthritis.76 We have previously synthesized a BN-Felbinac analogue where the only substitution 
on the azaborine stems from the boron atom77 (Figure 1.10). 
Figure 1.10: Previously Synthesized BN-Felbinac Analogue 
 
 Scheme 1.13 illustrates the synthetic route taken to synthesize our new BN-Felbinac 
analogue. Previously reported cross coupling techniques were tested using azaborines and it was 
 
76 Walsh, D. A.; Shamblee, D.A.; Welstead, W. J.; Sancilio, L.F. J. Med. Chem. 1982, 25, 446–451. 






found that the use of Pd(OAc)278 as the Pd precursor was suitable to successfully cross couple the 
azaborine mixture 3d with commercially available bromoacetate (4) to produce compound 5 in 
moderate yield (51%). Compound 5 was then deprotected using tetrabutylammonium fluoride 
(TBAF) to afford 6 in quantitative yield and a subsequent saponification yielded the desired new 
BN-Felbinac (7) analogue in 17%. This dramatic decrease in yield can be attributed to the small 
amount 3d at the beginning of this synthetic route as well as having to repeat the saponification 
conditions in order for the reaction to go to completion. Future studies should be able to attain a 
much higher yield.  
Scheme 1.13: Total Synthesis of BN-Felbinac 
 
 






Even though 3d was isolated as a mixture of both C5- and C3-borylated product, the 
cross coupling was selective for the C5-product. It was also possible to recover the pure C3-
borylated product after subjecting the mixture to the cross coupling conditions. (See SI for 
characterization)  
1.4.5 Mechanistic Studies  
To probe the mechanistic involvement of BBr3, various kinetic studies were performed to 
determine its order in the reaction. NMR experiments were done to measure the conversion versus 
time for three different concentrations (Figure 1.11). The concentrations selected were 0.50 M, 
0.75 M and 1.13 M equating to 2, 3, and 4.5 equivalents (with one data point being below the 
standard conditions and one being above). The conversion versus time graphs were created by 
plotting the disappearance of starting material versus time measured in minutes. These graphs were 
then fit to an exponential decay with the exponent equal to the kobs for each reaction. The log of 
the kobs was then plotted against the log of the concentration for each reaction and the slope of the 
























































(Conversion for each graph is defined as the disappearance of starting material) 
 
 Our hypothesis is that perhaps the C5 position can be considered the more negatively 
charged position and is therefore a harder nucleophile that has a stronger propensity to react with 
the hard borenium electrophile.79 This is in contrast to our previous work where the C3-position 
 












































reacts selectively with the soft Br2 electrophile.43,80 Our proposed mechanism is shown in Figure 
1.12.  
Figure 1.12: Proposed Mechanism for C5-Borylation 
 
 BBr3 first disproportionates to form the borenium cation as well as the corresponding BBr4- 
anion. The lone pair on the nitrogen can then kick down and push the electrons to attack the 
borenium cation. The resulting intermediate undergoes base-assisted loss of a proton to 
rearomatize the azaborine and afford the C5-substituted intermediate. This intermediate is then 
trapped with pinacol to yield the desired C5-borylated product. 
1.4.6 Future Directions and Conclusion 
 We have only scratched the surface when it comes to the importance and applications of 
this reaction. Future directions will allow this project to be greatly expanded in terms of substrate 
 






scope, synthesizing many new BN-isosteres of drug molecules, as well as further functionalizing 
our new BN-Felbinac analogue to create a new BN-CDK2 inhibitor. This would allow for the 
comparison of the bioactivity of our new BN-CDK2 inhibitor to the one previously synthesized 
(vide supra).  
 In summary, we have developed a new, metal-free method to directly borylate the C5 
position of our 1,2-azaborines. The scope of this reaction is tolerant of different substitution on the 
boron as well as at the C3 position of the azaborine. To demonstrate the application of this reaction, 
we synthesized a new BN isostere of the drug molecule felbinac. It also allows us to more fully 
explore the chemical space of biphenyl motifs by taking advantage of the unique reactivity of 
azaborines by directly functionalizing the para position of the azaborine. Mechanistic analysis 
suggests a second order in BBr3 consistent with the formation of a borenium cation. Additionally, 
the selectivity present can most likely be explained by the hard-soft acid-base chemistry. All-in-
all, this reaction greatly expands the chemical space of biphenyl motifs, while also allowing for 












1.5  Experimental Section 
1.5.1  General Information 
All oxygen- and moisture-sensitive manipulations were carried out in oven-dried glassware 
under an inert atmosphere (N2) using either standard Schlenk technique or a nitrogen-filled glove 
box.  
CH2Cl2, THF, Et2O, and pentane were dried using a Pure Process Technology solvent 
purification system, which passed the solvents through a neutral alumina column under argon. 
CD2Cl2, CDCl3, C6D6 and C2D2Cl4 were purified by distillation after drying over calcium hydride 
and degassed through a freeze-pump-thaw technique. All other reagents were purchased from 
commercial vendors (Acros Organics®, Millipore Sigma®, Oakwood Chemical®, or Combi-
Blocks®) and used as received unless otherwise stated. 
 1H, 11B, and 13C spectra were recorded on a Varian VNMRS 600 MHz, VNMRS 500 MHz, 
INOVA 500 MHz, or VNMRS 400 MHz spectrometer at both ambient temperature and 50 °C. 1H 
NMR spectra were internally referenced to chloroform-d (δ 7.26 ppm), methylene chloride-d2 (δ 
5.32 ppm), benzene-d6 (δ 7.16 ppm) or tetrachloroethane-d2 (δ 6.00 ppm). 11B NMR spectra were 
externally referenced to BF3•Et2O (δ 0.0 ppm).  
Infrared spectroscopy was performed on a Bruker ALPHA-Platinum FT-IR Spectrometer 
with an ATR-sampling module on OPUS software. High-resolution mass spectrometry data were 
obtained at the Boston College mass spectrometry facility on a JEOL AccuTOF instrument (JEOL 








Compound 1.59 (2.13 g, 78% yield) was synthesized as a colorless oil from N-TBS, 
B-Cl 1,2-azaborine 1.27 (1.27 was prepared according to literature procedures21) and 2-
mesityllithium in THF. A 20 mL vial was charged with 1.27 (2.00 g, 8.79 mmol) and 
tetrahydrofuran (16.0 mL) under nitrogen. To the flask was then added (2,4,6-
trimethylphenyl)lithium (2.22 g, 17.6 mmol) slowly over 7 minutes. After the addition, the reaction 
mixture was allowed to stir for an hour at room temperature. The crude mixture was dissolved in 
ethyl acetate (2 x 20.0 mL), washed with brine (30.0 mL), dried over NaSO4 and concentrated 
under reduced pressure. The crude reaction mixture was purified by column chromatography using 
silica in 100% hexanes to yield a single fraction. Spectra of the isolated compound matched 












Compound S1 (857 mg, 73% yield) was synthesized as a colorless oil from compound 
1.27 and a solution of molecular bromine in CH2Cl2. In the glovebox, an oven dried 50 mL round 
bottom flask equipped with a stir bar was charged with 1.27 (0.87 g, 3.8 mmol) and dissolved in 
CH2Cl2 (10.0 mL). The flask was cooled to –30 ºC using a dry ice/acetone bath, and a solution of 
molecular bromine (599 mg, 3.75 mmol, 192 μL) was added dropwise via a syringe to the reaction 
mixture. After the addition of bromine, the solution turned red-orange color. The reaction was 
allowed to stir for 1.25 hours, while warming to room temperature. The solution was then 
concentrated under reduced pressure, and the crude material was purified by vacuum distillation 












Compound 2b (330 mg, 30% yield) was synthesized as an off-white solid from 
compound S1 and 2-mesityllithium. In the glove box, compound S1 (857 mg, 2.79 mmol) was 
dissolved in Et2O (10.0 mL) at room temperature. Solid 2-mesityllithium (705 mg, 5.59 mmol) 
was added in portions to the stirred solution at room temperature. The reaction mixture was 
allowed to stir for 3 hours at room temperature, at which point 11B NMR analysis deemed the 
reaction to be complete. The solution was then concentrated under reduced pressure and 40 mL 
pentane was added. The resulting mixture was poured into 50.0 mL H2O, and the organic 
components were extracted with hexanes (3 x 50.0 mL). The combined organic layers were washed 
with brine, dried over NaSO4, passed through a fritted funnel, and concentrated under reduced 
pressure. The residue was reconstituted in a minimal amount of pentane and run through a silica 
gel column using 100% pentane until the product was observed on TLC, then 2% diethyl ether in 
hexanes was used to obtain the desired product. Spectra of the isolated compound matched 









Compound 2d (1.29 g, 54% yield) was synthesized as a colorless oil from compound 
1.27 and phenyl magnesium bromide in THF. In the glovebox, a 100 mL round-bottom flask 
equipped with a stir bar was charged with 1.27 (2.00 g, 8.79 mmol) and THF (20.0 mL). A 3.0 M 
solution of phenyl magnesium bromide (3.66 mL, 11.0 mmol, 1.25 equiv.) was added dropwise 
via a syringe in glove box and reaction mixture was allowed to stir for 12 hours at room 
temperature. At the conclusion of the reaction, solvent was removed under reduced pressure, and 
the product was purified by a plug of silica gel chromatography in the glovebox, with pentane as 















Compound 2c (500 mg, 87% yield) was synthesized as a light brown oil from 
compound 1.27 and n-butyllithium in ether. In the glovebox, to a 20 mL vial was added a magnetic 
stir bar, 1.27 (500 mg, 2.20 mmol) and diethyl ether (5.00 mL). The vial was then transferred to a 
fume hood and cooled to –78 °C in a dry ice/acetone bath before n-butyllithium (2.50 M, 0.967 
mL, 2.42 mmol) was added to the solution dropwise via a syringe. Once the addition was complete, 
the reaction was allowed to stir for 3 hours at room temperature. At the conclusion of the reaction, 
volatiles were removed under reduced pressure, and the crude material was purified by silica gel 
chromatography in the glovebox using 2% diethyl ether/pentane to yield the desired product. 
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 In the glovebox, to an oven dried pressure vial was added 1.59 (100 mg, 321 
μmol), BBr3 (241 mg, 964 μmol, 91.4 μL) and 2,6-ditert-butylpyridine (184 mg, 964 μmol, 208 
μL), all in tetrachloroethane (642 μL). The mixture was allowed to stir while refluxing at 140 °C 
for 2 hours. At the conclusion of the reaction, the mixture was cooled to –30 °C before a solution 
of 2,3-dimethylbutane-2,3-diol (114 mg, 964 μmol) and diethylethanamine (195 mg, 1.93 mmol, 
269 μL) was added dropwise and allowed to stir for 2 hours at room temperature. The resulting 
mixture was washed with sodium bicarbonate and the organic layer was dried over NaSO4. 
Volatiles were removed under reduced pressure, and the crude material was purified by silica gel 
chromatography using 100% hexanes to 10% hexanes/diethyl ether to yield compound 3a (121 













 In the glovebox, to an oven dried pressure vial was added 2b (120 mg, 308 
μmol), BBr3 (231 mg, 923 μmol, 87.5 μL) and 2,6-ditert-butylpyridine (176 mg, 923 μmol, 199 
μL), all in tetracholorethane (615 μL). The mixture was allowed to stir while refluxing at 140 °C 
for 2 hours. At the conclusion of the reaction, the mixture was cooled to –30 °C before a solution 
of 2,3-dimethylbutane-2,3-diol (109 mg, 923 μmol) and N,N-diethylethanamine (187 mg, 1.85 
mmol, 257 μL) was added dropwise and allowed to stir for 2 hours at room temperature. The 
resulting mixture was washed with sodium bicarbonate and the organic layer was dried over 
NaSO4. Volatiles were removed under reduced pressure, and the crude material was purified by 
silica gel chromatography using 100% hexanes to 10% hexanes/diethyl ether to yield compound 
3b (108 mg, 209 μmol, 68% yield). 1H NMR (600 MHz, CDCl3) δ 8.19 (d, J = 1.0 Hz, 1H), 7.98 
(d, J = 1.0 Hz, 1H), 6.78 (s, 2H), 2.29 (s, 3H), 2.05 (s, 6H), 1.31 (s, 12H), 0.92 (s, 9H), -0.00 (s, 
6H). 13C NMR (101 MHz, CDCl3) δ 1478.0, 147.2, 138.8, 137.0, 126.9, 83.6, 27.4, 24.8, 22.7, 
21.3, 19.2, -3.2. (3 carbon-boron signals are not observed). 11B NMR (192 MHz, CDCl3) δ 40.02, 
30.43. FTIR (thin film) ν cm–1 = 2963, 2932, 2859, 1601. HRMS (DART) calcd for 








In the glovebox, to an oven dried pressure vial was added 2c (100 mg, 401 
μmol), BBr3 (302 mg, 1.20 mmol, 114 μL) and 2,6-ditert-butylpyridine (230 mg, 1.20 mmol, 260 
μL), all in tetrachloroethane (802 μL) The mixture was allowed to stir and refluxed at 140 °C for 
2 hours. At the conclusion of the reaction, the mixture was cooled to –30 °C before a solution of 
2,3-dimethylbutane-2,3-diol (142 mg, 1.20 mmol) and N,N-diethylethanamine (244 mg, 2.41 
mmol, 335 μL) was added dropwise and allowed to stir for 2 hours at room temperature. The 
resulting mixture was brought into the wet box and washed with sodium bicarbonate before the 
organic layer was dried over NaSO4. Volatiles were removed under reduced pressure, and the crude 
material was purified by silica gel chromatography using 100% pentane to 5% pentane/diethyl 
ether to yield compound 3c (91.6 mg, 244 μmol, 61% yield). 1H NMR (400 MHz, CDCl3) δ 7.83 
(s, 1H), 7.83 – 7.78 (m, 1H), 6.74 (d, J = 11.1 Hz, 1H), 1.58 – 1.47 (m, 2H), 1.42 – 1.33 (m, 2H), 
1.29 (s, 12H), 1.24 – 1.17 (m, 2H), 0.95 – 0.85 (m, 12H), 0.50 (s, 6H). 13C NMR (126 MHz, 
CDCl3) δ 148.0, 146.4, 129.0 (br), 83.0, 29.7, 26.7, 26.1, 24.8, 21.6 (br), 19.0, 14.2, -1.4. (1 carbon-
boron signal is not observed). 11B NMR (128 MHz, CDCl3) δ 43.55, 32.06. FTIR (thin film) ν cm–









 In the glovebox, to an oven dried pressure vial was added 2d (200 mg, 743 
μmol), BBr3 (558 mg, 2.23 mmol, 211 μL) and 2,6-ditert-butylpyridine (426 mg, 2.23 mmol, 482 
μL), all in tetrachloroethane (1.49 mL). The mixture was allowed to stir while refluxing at 140 °C 
for 2 hours. At the conclusion of the reaction, the mixture was cooled to –30 °C before a solution 
of 2,3-dimethylbutane-2,3-diol (263 mg, 2.23 mmol) and N,N-diethylethanamine (451 mg, 4.46 
mmol, 621 μL) was added dropwise and allowed to stir for 2 hours at room temperature. The 
resulting mixture was brought into the wet box, washed with sodium bicarbonate, and the organic 
layer was dried over NaSO4. Volatiles were removed under reduced pressure, and the crude 
material was purified by silica gel chromatography using 100% pentane to 5% pentane/ether to 
yield compound 3d (162 mg, 411 μmol, 55% yield as a mixture of C5- and C3- borylated 
compounds with C3-borylated product as a minor impurity. Only the signals of the desired 
monoborylated compound are reported). 1H NMR (400 MHz, CD2Cl2) δ 7.99 (s, 1H), 7.85 (dd, J 
= 10.9, 1.2 Hz, 1H), 7.38 – 7.32 (m, 2H), 7.28 (dt, J = 4.5, 2.8 Hz, 3H), 6.60 (d, J = 10.8 Hz, 1H), 
1.32 (s, 12H), 0.89 (s, 9H), 0.07 (s, 6H). 13C NMR (101 MHz, CDCl3) δ 147.9, 147.0, 131.8, 126.7, 
83.2, 29.9, 26.8, 22.7, 18.9, -2.1 (3 carbon-boron signals are not observed). 11B NMR (128 MHz, 
CDCl3) δ 41.04, 32.48. FTIR (thin film) ν cm–1 = 2998, 2974, 2959, 2927, 2857, 1600. HRMS 







 In the glovebox, to an oven dried pressure vial was added 2d (100 mg, 371.38 
μmol), BBr3 (279.12 mg, 1.11 mmol, 105.73 μL) and 2,6-ditert-butylpyridine (213.15 mg, 1.11 
mmol, 240.84 μL), all in tetrachloroethane (743 μL). The mixture was allowed to stir while 
refluxing at 140 °C for 5 hours. At the conclusion of the reaction, the mixture was cooled to –30 
°C before a solution of 2,3-dimethylbutane-2,3-diol (132 mg, 1.11 mmol) and N,N-
diethylethanamine (225 mg, 2.23 mmol, 311 μL) was added dropwise and allowed to stir for 2 
hours at room temperature. The resulting mixture was brought into the wet box and washed with 
sodium bicarbonate before the organic layer was dried over NaSO4. Volatiles were removed under 
reduced pressure, and the crude material was purified by silica gel chromatography using 100% 
hexane to 10% hexane/ether to yield compound 3e (61.6 mg, 42% yield). 1H NMR (500 MHz, 
CD2Cl2) δ 8.18 (s, 1H), 8.05 (s, 1H), 7.30 (dp, J = 6.1, 2.0 Hz, 2H), 7.22 (dt, J = 4.4, 1.7 Hz, 3H), 
1.33 (s, 12H), 1.03 (s, 12H), 0.88 (s, 9H), 0.04 (s, 6H). 13C NMR (151 MHz, CD2Cl2) δ 157.2, 
152.6, 147.9 (br), 134.9, 128.6, 114.0 (br), 85.9, 85.0, 29.2, 27.2, 27.0, 25.0, 21.4, 16.4. (1 carbon-
boron signal is not observed) 11B NMR (160 MHz, CD2Cl2) δ 41.16, 31.92. FTIR (thin film) ν cm–
1 = 2976, 2957, 2931, 2859, 1600, 1504. HRMS (DART) calcd for C28H47B3NO4Si ([M+H]+) 








 In the glovebox, to an oven dried J-young tube was added 1.27 (25 mg, 110 
μmol), BBr3 (82.6 mg, 330 μmol, 31.3 μL) and 2,6-ditert-butylpyridine (63.0 mg, 330 μmol, 71.2 
μL), all in tetrachloroethane (439 μL) with 1,2-dichloroethane (10.9 mg, 110 μmol, 8.63 μL) as 
the internal standard. The mixture was allowed to reflux at 140 °C for 4 hours. NMR yield of 
reactive BBr2 intermediate was found to be 54% yield. 1H NMR (600 MHz, CD2Cl2) δ 8.62 (d, J 

















In the glovebox, a 4 mL pressure vessel was charged with S3 (1.13 g, 2.57 mmol,), bromoethylene 
(1.0 M, 10.29 mL), Pd(dppf)Cl2 (94.12 mg, 128.63 umol), KOH (433.04 mg, 7.72 mmol, 212.28 
uL), THF (15 mL) (including from vinylBr solution) and H2O (1.5 mL). The reaction mixture was 
allowed to stir at 65 °C for 1 hour. Volatiles were removed under reduced pressure, and the crude 
material was purified by silica gel chromatography using hexanes to yield compound S4 (844 mg, 
















In the glovebox, a 250 mL round bottom flask was charged with S4 (135 mg, 0.400 mmol), Pd/C 
(67.5 mg of 10 wt% Pd, 0.634 mmol) in ethylacetate (10 mL). The reaction mixture was allowed 
at room temperature under 1 atm H2 atmosphere for 4 hours. Volatiles were removed under reduced 
pressure, and the crude material was purified by silica gel chromatography using 15-40% CH2Cl2 
in pentane as an eluent afforded the desired product 2g (135 mg, 99%). 1H NMR (400 MHz, 
CD2Cl2) δ 6.75 (d, J = 7.0 Hz, 1H), 6.17 (s, 2H), 5.77 (d, J = 2.1 Hz, 1H), 5.64 (dd, J = 7.0, 2.2 Hz, 
1H), 1.91 (q, J = 7.5 Hz, 2H), 1.68 (s, 3H), 1.49 (s, 6H), 0.59 (t, J = 7.5 Hz, 3H), 0.31 (s, 9H), -
















In the glovebox, to a dried pressure vial was added Pd(OAc)2 (1.42 mg, 6.33 μmol), tri(o-
tolyl)phosphine (P(o-tol)3) (5.78 mg, 19.0 μmol), K3PO4 (224 mg, 1.05 mmol), and freshly distilled 
methyl 2-bromoacetate 4 (32.3 mg, 211 μmol, 19.4 μL) in THF (1.00 mL). The vial was then 
transferred to the wet box and degassed H2O (7.60 mg, 422 μmol, 7.60 μL) was added. The mixture 
was allowed to stir for a minute before compound 3d (100 mg, 253 μmol) in THF (1mL) was 
added. The mixture was then allowed to stir at 60 °C for 16 hours. At the conclusion of the reaction, 
the vial was brought back into the wet box and washed with degassed H2O before being extracted 
with ethyl acetate and dried over NaSO4. The crude material was then concentrated under reduced 
pressure and subjected to column chromatography in the glovebox (5% ether/pentane) to yield 
compound 5 (36.9 mg, 108 μmol, 51% yield). 1H NMR (600 MHz, CD2Cl2) δ 7.55 (dd, J = 11.0, 
1.8 Hz, 1H), 7.38 – 7.34 (m, 2H), 7.34 – 7.30 (m, 1H), 7.29 – 7.25 (m, 3H), 6.64 (d, J = 11.0 Hz, 
1H), 3.68 (s, 3H), 3.46 (s, 2H), 0.89 (s, 9H), 0.05 (s, 6H). 13C NMR (126 MHz, CDCl3) δ 172.6, 
144.8, 137.6, 132.7, 132.0, 126.7, 116.9, 51.9, 39.1, 26.8, 18.9, -2.1. (2 carbon-boron signals are 
not observed) 11B NMR (192 MHz, CD2Cl2) δ 38.56. FTIR (thin film) ν cm–1 = 3006, 2954, 2930, 









In the glovebox, a 20 mL vial containing a magnetic stir bar was charged with compound 5 (36.9 
mg, 108 μmol) and THF (2.00 mL). A solution of tetrabutylammonium fluoride (TBAF), 1.0 M in 
THF (33.9 mg, 130 μmol, 37.6 μL) was added to the stirred solution and the reaction mixture was 
allowed to stir for 1 hour at room temperature. At the conclusion of the reaction, the mixture was 
concentrated under reduced pressure to yield a yellow, crude paste. The crude product was purified 
by silica gel chromatography in the glovebox using 4:1 ether/pentane as eluent to yield compound 
6 (24.5 mg, 108 μmol, 99% yield). 1H NMR (400 MHz, CDCl3) δ 8.22 (s, 1H), 7.79 – 7.74 (m, 
2H), 7.71 (dd, J = 11.5, 1.8 Hz, 1H), 7.45 – 7.35 (m, 3H), 7.35 – 7.29 (m, 1H), 7.19 (dd, J = 11.4, 
2.2 Hz, 1H), 3.71 (s, 3H), 3.46 (s, 2H). 13C NMR (101 MHz, CDCl3) δ 172.6, 146.6, 133.4, 132.2, 
129.0, 128.1, 116.3, 52.0, 38.5. (2 carbon-boron signals are not observed) 11B NMR (160 MHz, 
CD2Cl2) δ 33.25. FTIR (thin film) ν cm–1 = 3348, 1724, 1630, 1545. HRMS (DART) calcd for 












In a glove box, a 20 mL vial was charged with a stir bar, compound 6 (24 mg, 106 μmol), NaOH 
(8.46 mg, 211 μmol, 3.97 μL), and MeOH (1 mL). The reaction mixture was allowed to stir for a 
total of 33 hours at varied temperatures (rt to 60 °C) under an inert atmosphere before removing 
solvent under reduced pressure. The crude solid was then redissolved in ethyl acetate and H2O 
before HCl (2M) was added in dropwise until the pH reached ~2. The organic layer was then 
extracted with ethyl acetate and concentrated under reduced pressure to compound 7 (4 mg, 18.8 
μmol, 18% yield). 1H NMR (400 MHz, CDCl3) δ 8.22 (s, 1H), 7.78 – 7.73 (m, 2H), 7.71 (dd, J = 
11.6, 1.8 Hz, 1H), 7.45 – 7.35 (m, 3H), 7.33 (d, J = 7.9 Hz, 1H), 7.20 (dd, J = 11.4, 2.2 Hz, 1H), 
3.49 (s, 2H). 13C NMR (101 MHz, CDCl3) δ 176.7, 146.5, 133.5, 132.2, 129.1, 128.1, 115.6, 38.1. 
(2 carbon-boron signals are not observed) 11B NMR (192 MHz, CDCl3) δ 32.85. FTIR (thin film) 
ν cm–1 = 3378, 3051, 3033, 3011, 2922, 2852, 1700, 1624, 1542. HRMS (DART) calcd for 











In the glovebox, to a dried pressure vial was added Pd(OAc)2 (1.42 mg, 6.33 μmol), Tri(o-
tolyl)phosphine (P(o-tol)3) (5.78 mg, 19.0 μmol), K3PO4 (224 mg, 1.05 mmol), and freshly distilled 
methyl 2-bromoacetate 4 (32.3 mg, 211 μmol, 19.4 μL) in THF (1.00 mL). The vial was then 
transferred to the wet box and degassed H2O (7.60 mg, 422 μmol, 7.60 μL) was added. The mixture 
was allowed to stir for a minute before compound 3d (100 mg, 253 μmol) in THF (1 mL) was 
added. The mixture was then allowed to stir at 60 °C for 16 hours. At the conclusion of the reaction, 
the vial was brought back into the wet box and washed with degassed H2O before being extracted 
with ethyl acetate and dried over NaSO4. The crude material was then concentrated under reduced 
pressure and subjected to column chromatography in the glovebox (5% ether/pentane) to yield 
compound S2 as the second fraction (trace amounts). 1H NMR (400 MHz, CDCl3) δ 7.92 (d, J = 
6.3 Hz, 1H), 7.45 (d, J = 6.8 Hz, 1H), 7.32 (p, J = 3.6, 3.0 Hz, 2H), 7.20 (dd, J = 4.2, 2.1 Hz, 3H), 
6.44 (t, J = 6.4 Hz, 1H), 1.01 (d, J = 1.3 Hz, 12H), 0.86 (d, J = 1.2 Hz, 9H), -0.01 (d, J = 1.3 Hz, 
6H). 13C NMR (101 MHz, CDCl3) δ 149.7, 140.3, 132.4, 126.0, 112.1, 82.6, 26.9, 24.9, 24.5, 18.9, 
-2.1. (2 carbon-boron signals are not observed) 11B NMR (192 MHz, CDCl3) δ 40.52, 31.70. FTIR 
(thin film) ν cm–1 = 2975, 2973, 2957, 2858, 1599. HRMS (DART) calcd for C22H36B2NO2Si 







1.5.3 Kinetic Experiments 
General Experimental Procedure for rate measurements by 1H NMR 
In a glovebox, a J-Young tube was charged with N-TBS, B-Mes 1,2-azaborine (25.0 mg, 80.3 
μmol), 2,6-ditert-butylpyridine (40.1 mg, 241 μmol, 52.1 μL), BBr3 in varied concentrations (0.50 
M, 0.75 M, 1.13 M) and internal standard 1,1,2,2-tetrachloroethane (13.5 mg, 80.3 μmol, 8.42 μL) 
all in C2D2Cl4. A 1H NMR spectrum was collected every minute and disappearance of starting 














































































































































































1.5.4.1  Analysis of C4 Ethyl Product 
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